| Dec'17 | ||||||
|---|---|---|---|---|---|---|
Revenue | ||||||
481 | ||||||
Cost of Revenue | ||||||
15 | ||||||
Gross Profit | ||||||
466 | ||||||
Operating costs and expenses: | ||||||
Research and development expenses, net: | ||||||
4,881 | ||||||
Participation in research and development expenses | ||||||
-823 | ||||||
Research and development expenses, net | ||||||
4,058 | ||||||
General, administrative and marketing expenses | ||||||
2,394 | ||||||
Operating loss | ||||||
-5,986 | ||||||
Financial income | ||||||
74 | ||||||
Financial expenses | ||||||
110 | ||||||
Financial expenses, net | ||||||
-36 | ||||||
Comprehensive loss | ||||||
-6,022 | ||||||
Basic and diluted loss per ordinary share (NIS/USD) | ||||||
0.05 | ||||||
Weighted average ordinary shares outstanding | ||||||
133,187 | ||||||